Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-052471
Filing Date
2017-08-17
Accepted
2017-08-17 16:33:53
Documents
4
Effectiveness Date
2017-08-17

Document Format Files

Seq Description Document Type Size
1 S-8 a17-20288_1s8.htm S-8 92423
2 EX-5.1 a17-20288_1ex5d1.htm EX-5.1 13199
3 EX-23.2 a17-20288_1ex23d2.htm EX-23.2 4328
4 GRAPHIC g202881kgi001.jpg GRAPHIC 2580
  Complete submission text file 0001104659-17-052471.txt   114871
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-220016 | Film No.: 171039014
SIC: 2834 Pharmaceutical Preparations